Fundraising FoxArexera Therapeutics
1 known investors
Find your way into Arexera Therapeutics
Sign up to see every warm intro you have to Arexera Therapeutics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Arexera Therapeutics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Arexera Therapeutics, formerly Atalanta Therapeutics, is a biotechnology company developing small interfering RNA (siRNA) medicines to treat severe neurological diseases, with a franchise focused on Huntington's disease.
Investors · 1
Frequently asked questions
- What does Arexera Therapeutics do?
- Arexera Therapeutics, formerly Atalanta Therapeutics, is a biotechnology company developing small interfering RNA (siRNA) medicines to treat severe neurological diseases, with a franchise focused on Huntington's disease.
- Who are Arexera Therapeutics's investors?
- Arexera Therapeutics's investors include RiverVest Venture Partners.